Gastrointestinal Cancer News

Multicomponent interventions effectively increase colorectal cancer screening with colonoscopy or fecal occult blood testing, according to a CDC report.

Cancer Prevention Pharmaceuticals Inc. launched a phase 2 clinical trial to assess CPP-1X, a therapy for the treatment of gastric cancer previously given orphan drug designation from the FDA, in patients with precancerous gastric lesions, according to a press release.

ASCO today issued a position statement that proposes a wide range of cost-cutting strategies that can be tested to help lower drug costs based on a standard definition of value.

Halozyme Therapeutics and Genentech initiated a multiarm clinical trial that will evaluate PEGPH20 in combination with atezolizumab for previously treated patients with metastatic pancreatic ductal adenocarcinoma.

No Stomach For Cancer awarded $100,000 worth of grants to fund research related to immunotherapy and use of blood biomarkers to predict early recurrence of stomach cancer.

A new trial has been launched to help researchers better understand the link between new-onset diabetes and pancreatic cancer.

The FDA has taken several actions in the past week related to oncology treatments.

CSA Medical announced it has received FDA (510K) clearance for the expansion of its truFreeze catheter liquid nitrogen spray cryotherapy system to include a third spray kit, which will be referred to as the Rapid AV Spray Kit.

Men aged 40 to 65 years with chronic hepatitis B and a high burden of metabolic risk factors had increased risk for hepatocellular carcinoma, especially is they were smokers, according to a recently published study.

Blended cognitive behavior therapy improved fear of recurrence in breast, prostate and colorectal cancer survivors, according to results of the SWORD clinical study